FDA approves Gardasil for boys, young men

10/19/2009 | Bloomberg

The FDA has authorized Merck & Co. to begin promoting its vaccine Gardasil to protect males ages 9 to 26 against genital warts caused by human papillomavirus infections. The approval is "an important milestone" for Merck and in the treatment of HPV-related diseases, a Merck official said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ